In conclusion, our study demonstrates that the high expression of CRYAB is closely correlated with cancer metastasis and shorter survival time in patients with gastric cancer, and CRYAB promotes EMT and metastasis of gastric cancer cells via NF‐κB signalling pathway, thus possibly providing a promising candidate for treatment against gastric cancer metastasis. Here, NFKB1 is linked to gastric cancer.